ClinicalTrials.Veeva

Menu

Elderberries and Obesity

Washington State University logo

Washington State University

Status

Completed

Conditions

Fuel Management

Treatments

Other: Placebo beverage
Other: Elderberry juice

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Previous studies in humans indicate that anthocyanin-rich berries can positively alter fat oxidation and insulin sensitivity. This study will determine if this is also true with elderberries, which are a more concentrated source of anthocyanins compared to other commonly consumed berries.

Enrollment

10 patients

Sex

All

Ages

22 to 75 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Women and Men between 22 and 75 years of age with a body mass index of 25 kg/m2 or above.

Exclusion criteria

  • Are not fully vaccinated against COVID-19 (at least 2-weeks out from final dose at time of staff meeting)
  • Have a body mass index less than 25 kg/m2
  • Are younger than 22 years of age, or older than 75 years of age
  • Pregnant, lactating, or intending to become pregnant during the study period, or have given birth in the past year
  • Known allergy or intolerance to elderberries
  • History of bariatric surgery or nutrient malabsorption disease (such as celiac disease) or other metabolic disorders requiring a special diet that is not in accord with the diet behavior requested for this study
  • Adherence to restrictive (vegetarian or vegan) or extreme (fad [ex. Ketogenic or Atkins] or quick weight loss/gain) diet patterns and unwillingness to consume a conventional, omnivorous diet and maintain body weight
  • Habitual use of tobacco or marijuana (including vaping) products in the last 6 months
  • Diagnosis or treatment of cancer in the past 3 years
  • Crohn's disease or diverticulitis
  • Suspected or known strictures, fistulas or physiological/mechanical GI obstruction
  • Use of certain medications (prescription or over-the-counter) that may interfere with the study objectives, including blood thinning medications
  • Type 2 diabetes requiring the use of medication
  • Fasting blood glucose > 125 mg/dL
  • Unable or unwilling to give informed consent or communicate with study staff
  • Self-report of alcohol or substance abuse within the past 12 months and/or current treatment for these problems (long-term participation in Alcoholics Anonymous is not an exclusion)
  • Other medical, psychiatric, or behavioral factors that in the judgment of the Principal Investigator may interfere with study participation or the ability to follow the intervention protocol

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Double Blind

10 participants in 2 patient groups, including a placebo group

Elderberry juice
Experimental group
Description:
Participants will consume elderberry juice twice/day for 1-week.
Treatment:
Other: Elderberry juice
Placebo beverage
Placebo Comparator group
Description:
Participants will consume placebo beverage twice/day for 1-week.
Treatment:
Other: Placebo beverage

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems